An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
Clinical Trial Grant
Awarded By
Alnylam Pharmaceuticals
Start Date
February 5, 2025
End Date
February 2, 2028
Awarded By
Alnylam Pharmaceuticals
Start Date
February 5, 2025
End Date
February 2, 2028